Related Experiment Video

Updated: Apr 11, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.8K

Differences in clinical characteristics of community-acquired pneumonia with respiratory failure caused by different

Xulong Cai1, Bangcong Hang2, Chenrong Zhou1

  • 1Department of Pediatrics, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, 224000, China.

Respiratory Medicine
|April 9, 2026
PubMed

Insights

Community-acquired pneumonia (CAP) with respiratory failure in children is often caused by Mycoplasma pneumoniae (MP), respiratory syncytial virus (RSV), and bocavirus (BoV). Different pathogens present unique clinical characteristics and illness durations.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Clinical Microbiology

Background:

  • Community-acquired pneumonia (CAP) poses a significant threat to children's health, with respiratory failure being a severe complication.
  • Understanding the etiological agents and their clinical impact is crucial for effective management.

Purpose of the Study:

  • To analyze the clinical characteristics of pediatric CAP presenting with respiratory failure based on the causative pathogens.
  • To compare the clinical presentations and outcomes associated with Mycoplasma pneumoniae (MP), respiratory syncytial virus (RSV), and bocavirus (BoV) infections.

Main Methods:

  • Retrospective analysis of clinical data from children diagnosed with CAP and respiratory failure.
  • Identification and distribution analysis of infectious pathogens, focusing on MP, RSV, and BoV.
  • Statistical comparison of clinical features, illness duration, hospitalization length, and treatment requirements among pathogen groups.

Main Results:

  • Mycoplasma pneumoniae (MP), respiratory syncytial virus (RSV), and bocavirus (BoV) were the most frequent pathogens identified.
  • Patients with multiple-pathogen infections had a longer duration of illness before hospitalization compared to single-pathogen infections.
  • The MP group exhibited longer pre-hospitalization illness duration, extended hospital stays, and required the most prolonged oxygen therapy, often exceeding 7 days.

Conclusions:

  • MP, RSV, and BoV are prevalent pathogens causing CAP with respiratory failure in children.
  • The specific pathogen identified in pediatric CAP with respiratory failure significantly influences clinical manifestations and disease course.
Abstract

Keywords:
ChildrenClinical characteristicsCommunity-acquired pneumoniaRespiratory failureRespiratory pathogens

More Related Videos

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

13.3K
Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

6.0K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
57
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.6K